Author: Jessie Mowery

TRiNDS’s Strategic Solutions refers to the specialty services we offer to help clients complete high-quality, rare neuromuscular disease (NMD) clinical trials. Included under the Strategic Solutions umbrella are our Data and Safety Monitoring Board (DSMB), Genetic Confirmation, Study Measurements, and Community Engagement services. Our clients’ first experience with TRiNDS is usually through one of our… Read more »

TRiNDS partners with innovative clients working in rare disease research around the world. We prioritize providing clients with high quality, uninterrupted support from our experienced and professional team members. To provide our clients with continuous support, TRiNDS fosters a predominantly work from home (WFH) environment that is project-centered, emphasizes collaboration, and cultivates social connections within… Read more »

In the US, September is observed as Muscular Dystrophy Awareness Month (MDAM). The are multiple days of observance for varying muscular dystrophies in September, including World Duchenne Awareness Day (WDAD). TRiNDS happily supports and recognizes both MDAM and WDAD. WDAD is in September and is held on the 7th of the month. This day was… Read more »

Every successful clinical trial has an effective and competent clinical operations team operating from behind the scenes. Clinical operations teams need to meet several different criteria to be successful. Experience in trial management, clinical trial site selection and start-up, ethical committee review supervision, and time and budget management are all integral to a successful clinical… Read more »

TRiNDS provides contract research services around the world for clients working in rare neuromuscular disease (NMD) research. Our commitment to cultivating excellence in our expert, specialized, experienced, and knowledgeable team members allows us to bring high level support to every project, every day. Part of providing high quality support to our clients is fostering collaboration… Read more »

TRiNDS partners with innovative clients working in rare neuromuscular disease (NMD) research to provide contract research services around the world. A major component to our success is our commitment to cultivating excellence. Our expert, specialized, experienced, and knowledgeable teams need to consistently bring high level support to every project, every day. For us to continue… Read more »

TRiNDS partners with innovative clients working in rare neuromuscular disease research to provide contract research services around the world. Our specialized, experienced, and knowledgeable teams bring high level, continuous service, specialized processes, and strong relationships to every trial we support. TRiNDS focuses on rare neuromuscular diseases (NMDs) because of the unique clinical care needs and… Read more »

Invariably, clinical trials rely on data to answer scientific questions. It is essential that every data point is collected, cleaned, verified, and transferred appropriately and on time. Data managers help design the study’s data collection systems, the system’s maintenance and monitoring methodologies, and the plans for data exchange between systems. The unique demands of rare… Read more »

November 18, 2022 TRiNDS Team Spotlight: Sarah MacCallum, Clinical Project Lead All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to highlight Sarah MacCallum, Clinical Project Lead. We sat down with Sarah to learn more about her and her work…. Read more »

October 26, 2022 TRiNDS Fall Retreat 2022 Highlights TRiNDS partners with innovative clients working in rare disease research around the world. We prioritize providing clients with high quality, uninterrupted support from our experienced and professional team members. To provide our clients with continuous support, TRiNDS fosters a predominantly work from home (WFH) environment that is… Read more »

  September 22, 2022 TRiNDS Clinical Operations Services Behind every successful clinical trial is an efficient and skilled clinical operations team. Clinical operations teams need to be competent in several areas to be successful. From trial management, to clinical trial site selection and start-up, to ethical committee review supervision, these teams need to be able… Read more »

August 12, 2022 TRiNDS Strategic Solutions: Specialized Services for Specialized Research TRiNDS Strategic Solutions are the specialty services we offer to help clients successfully complete high-quality, rare neuromuscular disease (NMD) clinical trials. Our Strategic Solutions includes Data and Safety Monitoring Board (DSMB), Genetic Confirmation, Study Measurements, and Community Engagement services. Oftentimes, our clients’ first experience… Read more »

June 17, 2022 In the United States, we celebrate Juneteenth National Independence Day and LGBTQIA+ Pride Month in June. TRiNDS reflects each year upon the need to combat racism and anti- LGBTQIA+ bias in our work to support high quality clinical research to rare neuromuscular disease communities. The history of clinical research in the US… Read more »

May 3, 2022 TRiNDS and Working From Home: The Importance of Workplace Flexibility TRiNDS partners with innovative clients conducting rare neuromuscular disease research around the world. Our priority is to give clients high level, continuous support from specialized, experienced, and knowledgeable teams. One of the keys to a successful trial is retention of a qualified… Read more »

March 2, 2022 TRiNDS Continuing Education Program: Investing in Excellence TRiNDS partners with innovative clients working in rare disease research. One of the keys to our success is our commitment to maintaining a culture of excellence. Our specialized, experienced, and knowledgeable teams of experts need to bring high level support to every project, every day…. Read more »

February 2, 2022 Genetic Confirmation: A Step You Can’t Afford to Get Wrong Neuromuscular disorders (NMDs) are frequently caused by genetic mutations. However, the genetic causes of Duchenne muscular dystrophy (DMD), Spinal Muscular Atrophy (SMA), and other rare NMDs are often difficult to interpret due to differences in laboratory reporting, evolving genetics technology, and complex… Read more »